ACAD
Acadia Pharmaceuticals Inc.
$17.83−0.49 (−2.67%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
May 27, 2004 – Nov 18, 2026, Dividends reinvested
- Final balance
- $26,612
- CAGR
- +4.45%
- Max drawdown
- −96.29%
Trailing returns (%)
ACAD's average annual return was −4.92% over the last 10 years and 3.07% over the last 20 years, through Nov 18, 2026. $10,000 in ACAD on Nov 18, 2016 fell to $6,038 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- −6.75%
- 3M
- −40.92%
- 6M
- −13.82%
- YTD
- −33.25%
- 1Y
- −25.08%
Per year
- 3Y
- −7.92%
- 5Y
- −1.21%
- 10Y
- −4.92%
- 15Y
- +20.70%
- 20Y
- +3.07%
- Since 2004
- +4.45%
Annual returns
2004 from May 27 · 2026 through Nov 18
ACAD returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | −33.25% |
| 2025 | +45.56% |
| 2024 | −41.39% |
| 2023 | +96.67% |
| 2022 | −31.79% |
| 2021 | −56.34% |
| 2020 | +24.96% |
| 2019 | +164.56% |
| 2018 | −46.30% |
| 2017 | +4.40% |
| 2016 | −19.10% |
| 2015 | +12.28% |
Metrics
Since 2004| Volatility | 85.30% |
|---|---|
| Sharpe ratio | 0.43 |
| Sortino ratio | 0.78 |
| Calmar ratio | 0.05 |
| Longest drawdown | 7.2 years |
Worst drawdowns
Since 2004| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −96.3% | Mar 2006 | Nov 2010 | Jun 2013 | 7.2 years |
| −77.2% | Jul 2020 | Jun 2022 | Not yet | 6.4 years so far |
| −74.0% | Jul 2015 | Aug 2018 | Dec 2019 | 4.4 years |
| −40.8% | Feb 2014 | Apr 2014 | Dec 2014 | 9 months |
| −38.4% | Dec 2019 | Mar 2020 | Apr 2020 | 5 months |